We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AG Deals Not Outlawed by 3rd Circuit’s Anti Pay-for-Delay Stance: Lower Court
AG Deals Not Outlawed by 3rd Circuit’s Anti Pay-for-Delay Stance: Lower Court
December 21, 2012
A New Jersey court has thrown out an antitrust lawsuit against Teva and GlaxoSmithKline (GSK), ruling that patent settlements involving authorized generic agreements are not illegal.